Pfizer/Wyeth Merger Would Offer Diversification, Switch Outlet

Pfizer's potential acquisition of Wyeth could swing the company back to a diversified portfolio - including the return of a consumer health division -and help offset a dwindling pipeline and the looming generic competition that threatens Rx sales, analysts say